Post Subject #42   NVO TREND1 04/28/17 01:31:13 PM #41   Long term... this is a BIG winner .. Xxmatty87xx 04/13/17 01:58:32 PM #40   I wonder whether NVO, Sanofi or LLY is north40000 09/13/16 02:54:42 PM #39   Close to 52 week low. abrooklyn 08/20/16 02:23:35 PM #38   Ripe for a fall... like an anvil out Pro-Life 12/07/15 08:57:06 PM #37   NVO MONTHLY TREND1 08/26/15 02:28:56 PM #36   Novo Nordisk to initiate phase 3a development of TREND1 08/26/15 02:14:44 PM #35   NVO PF TREND1 08/26/15 02:06:57 PM #34   Inst % Owned = 7% TREND1 08/26/15 02:05:47 PM #33   EPS= 10.10 TREND1 08/26/15 02:04:30 PM #32   NVO D TREND1 08/26/15 02:03:24 PM #31   NVO D TREND1 11/04/14 04:33:11 PM #30   FROM DEW TREND1 10/30/14 11:25:38 AM #29   THANKS TREND1 10/28/14 01:36:22 PM #28   Yes—see #msg-107612584. DewDiligence 10/28/14 01:02:13 PM #27   Was NOV drop due to reaction of SNY TREND1 10/28/14 12:01:34 PM #26   NVO D TREND1 10/25/14 03:04:06 PM #25   Eli Lilly & Co.'s Type 2 TREND1 10/24/14 12:16:23 AM #24   NVO EPS =9.40 TREND1 10/23/14 09:20:16 PM #23   ***NOW COMPARE NVO M WITH SPX M TREND1 10/23/14 09:04:54 PM #22   No action yet. DewDiligence 10/23/14 04:53:03 PM #21   NVO M TREND1 10/23/14 04:39:58 PM #19   NVO is world's biggest maker of insulin TREND1 10/23/14 04:08:43 PM #18   NVO D TREND1 10/23/14 04:06:45 PM #17   NVO 1 TREND1 10/23/14 04:01:33 PM #16   DEW How did this turn out ? TREND1 10/23/14 03:39:33 PM #14   Novo is studying the injected drug - already TREND1 10/23/14 03:31:29 PM #11   Share buyback started Feb 1st. Also a surfer 03/01/14 03:32:56 PM #10   Final push before reversal IMO. Ichauway 03/01/14 03:13:13 PM #9   Agreed but I do see this eventually higher. a surfer 02/25/14 12:58:49 PM #8   Looks like a good day to take some profits. Ichauway 02/25/14 12:52:36 PM #7   This thing is a monster!! Share buy a surfer 02/25/14 12:49:57 PM #6   diabetes market to be $58 billion by 2018 Ichauway 12/31/13 10:12:05 PM #5   A recent article on insidermonkey makes an interesting investora2z 08/08/13 06:35:24 AM #4   Great company, but the valuation is a little DewDiligence 07/18/13 12:31:19 PM #3   Novo is a good growth story as far investora2z 07/18/13 07:19:49 AM #2   Novo bets on high-price niche for obesity drug Wildbilly 12/11/12 06:03:19 PM #1   FDA extends NDA review of NVO’s degludec and DewDiligence 06/08/12 08:25:14 AM Post Subject

© 2017 InvestorsHub.Com, Inc.